TherOx Appoints D. Keith Grossman to Its Board of Directors

TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced the appointment of D. Keith Grossman to its board of directors, according to a Business Wire press release.

Grossman has over 30 years of experience in the medical device field. Grossman served most recently, and for the second time, as the president, chief executive officer and director of Thoratec Corporation, leading up to its 2015 sale to St. Jude Medical. 

Read the full press release here.